Characterization of a chemically modified plant cell culture expressed human α-Galactosidase-A enzyme for treatment of Fabry disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characterization of a chemically modified plant cell culture expressed human α-Galactosidase-A enzyme for treatment of Fabry disease

Published:2015-02 Issue:2 Volume:114 Page:259-267
ISSN:1096-7192
Container-title:Molecular Genetics and Metabolism
language:en
Short-container-title:Molecular Genetics and Metabolism

Author:

Kizhner Tali,Azulay Yaniv,Hainrichson Mariana,Tekoah Yoram,Arvatz Gil,Shulman Avidor,Ruderfer Ilya,Aviezer David,Shaaltiel Yoseph

Funder

Protalix Biotherapeutics

Office of the Chief Scientist of the Ministry of Industry, Trade and Labor, Israel

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference44 articles.

1. Lysosomal storage disease: revealing lysosomal function and physiology;Parkinson-Lawrence;Physiology,2010

2. A case of “Angeio-Keratoma”;Anderson;Br. J. Dermatol.,1898

3. Ein Beitrag zur Kenntniss der Purpura haemorrhagica nodularis (Purpura papulosa haemorrhagica Hebrae);Fabry;Arch. Dermatol. Syph.,1898

4. Fabry disease;Germain;Orphanet J. Rare Dis.,2010

5. Replacement therapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry's disease;Brady;N. Engl. J. Med.,1973

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene therapy with lipid nanoparticles for Fabry disease: Leveraging E-selectin for targeted delivery to endothelial cells;Journal of Drug Delivery Science and Technology;2024-09

2. Opportunities for nanomaterials in enzyme therapy;Journal of Controlled Release;2024-08

3. Green biotherapeutics: overcoming challenges in plant-based expression platforms;Plant Biotechnology Reports;2024-06-21

4. Fabry disease: a rare disorder calling for personalized medicine;International Urology and Nephrology;2024-04-13

5. Pegunigalsidase alfa: a novel, pegylated recombinant alpha-galactosidase enzyme for the treatment of Fabry disease;Frontiers in Genetics;2024-04-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3